Lion dishes up $1.9bn Weetabix partial exit

In the latest example of cross-border investment, London-based Lion has sold a controlling stake in UK-based Weetabix to a Chinese state-run enterprise.

To view this content you must sign in:

Not yet registered? Join today to access Private Equity International's industry insights and updates.